Stay updated on Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.

Latest updates to the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as the prior Revision: v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding lapse notice and operating status message have been added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedMinor UI/text updates: the glossary option is shown, capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 is visible on the page, replacing v3.3.3. No substantive changes to study details or content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page's Locations section was updated with numerous new sites across multiple countries and regions, and several previously listed locations were removed.SummaryDifference2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.